Try our Advanced Search for more refined results
January 19, 2012
Merck & CIE et al v. Macoven, et al
Case Number:
6:12-cv-00027
Court:
Nature of Suit:
Judge:
Firms
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
June 23, 2014
Merck Supplement Patents Nixed In 1st Pharma AIA Reviews
The Patent Trial and Appeal Board on Friday invalidated many claims of four dietary supplement patents that Swiss Merck KgaA accused biotech firm Gnosis SpA of infringing, in what an attorney for Gnosis said may be the first inter partes review involving pharmaceutical-related patents.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login